Inhibikase Therapeutics (IKT) Total Debt (2019 - 2025)
Inhibikase Therapeutics (IKT) recorded Total Debt of $37,944 in Q2 2025, down 75.1% from $152,224 a year earlier and down 49.3% from the prior quarter.
Powered by 
Analysis
Inhibikase Therapeutics (IKT) Total Debt (2019 - 2025) Analysis & Trends
At the end of FY2024, Inhibikase Therapeutics reported Total Debt of $110,517, down 26.4% from FY2023.
- Annual Total Debt has a four-year compound annual growth rate of -23.3% (FY2020 to FY2024).
- Across earlier years, Total Debt came in at $150,095 in FY2023 (+2.9%), $145,836 in FY2022 (-41.4%), $248,911 in FY2021 (-22.0%) and $318,995 in FY2020.
- The Q2 2025 figure is the lowest quarterly Total Debt in data going back to Q4 2020.
- On a year-over-year basis, Total Debt has declined for four consecutive quarters, with an average decline of 17.6% over the last eight quarters.
- Peak year-over-year performance for Total Debt in the last five years was growth of 4.9% in Q3 2023, against a decline of 75.1% in Q2 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $74,772 (Q1 2025), $110,517 (Q4 2024) and $145,210 (Q3 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 49.50 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 44.65 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 80.90 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 53.78 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -6.68 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 54.01 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 26.23 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 62.67 Bn |
| 10 | Inhibikase Therapeutics | 281.11 Mn | -420.36 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 37,944.00 |
| Mar 31, 2025 | 74,772.00 |
| Dec 31, 2024 | 110,517.00 |
| Sep 30, 2024 | 216,872.00 |
| Jun 30, 2024 | 329,480.00 |
| Mar 31, 2024 | 431,773.00 |
| Dec 31, 2023 | 381,784.00 |
| Sep 30, 2023 | 149,030.00 |
| Jun 30, 2023 | 147,966.00 |
| Mar 31, 2023 | 146,901.00 |
| Dec 31, 2022 | 145,836.00 |
| Sep 30, 2022 | 142,048.00 |
| Dec 31, 2021 | 248,911.00 |
| Sep 30, 2021 | 248,911.00 |
| Jun 30, 2021 | 248,911.00 |
| Mar 31, 2021 | 2.49 Mn |
| Dec 31, 2020 | 637,990.00 |
| Dec 31, 2019 | 373,794.00 |
API Access
Inhibikase Therapeutics Total Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-debt&ticker=IKT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-debt", "ticker": "IKT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-debt&ticker=IKT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();